Furley Bioextracts carves a name for itself in the biotech sector, powered by a father-son duo.
Malaysia Debt Ventures Bhd, a technology financier and is a subsidiary of Malaysia's Ministry of Finance, has launched its new corproate strategy, involving the allocation of RM200 million in financing to support new high growth sectors.
The chairman and founder of India’s largest biotech company sees a bright future for Malaysia’s biotech ambitions, but notes that the lack of sufficient highly skilled talent could derail ambitions.
With great power comes great responsibility. For Rizatuddin Ramli, the boyish-faced chief executive officer of Malaysian Bio-XCell Sdn Bhd, one can say, with great investment, comes great expectations.
A government-industry collaboration to increase the talent base in the field of biotechnology got off to a successful start. Participants in the Agilent Bio-analytical Industrial Development Program completed their Phase 1 training and received their industry certificates in Biochemical Instrumentation and Lab Practices on Aug 14.